Related Experiment Video
Updated: Feb 11, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes
Insights
Cardiovascular disease, particularly atherosclerotic coronary artery disease, remains a significant global health challenge. This review explores its scope, pathobiology, biomarkers, and the role of inflammation in precision medicine for improved diagnosis and management.
Area of Science:
- Cardiovascular Medicine
- Pathobiology
- Precision Medicine
Background:
- Cardiovascular disease (CVD) and atherosclerotic coronary artery disease (CAD) represent a major global health and economic burden.
- Despite historical observations and evolving knowledge of atherosclerosis, significant gaps in understanding persist.
- Key pathobiological aspects include inflammation, vascular injury response, and impaired homeostasis.
Purpose of the Study:
- To summarize the current scope and challenges of coronary artery disease.
- To review emerging pathobiological constructs, clinical phenotypes, and biomarkers.
- To discuss the 'inflammation hypothesis' and the integration of pathobiology with precision medicine for future advancements.
Main Methods:
- Literature review and synthesis of existing research on atherosclerosis and coronary artery disease.
- Analysis of current understanding of disease pathobiology, including inflammation and vascular injury.
- Examination of clinical trials, biomarkers, and the application of precision medicine.
Main Results:
- Coronary artery disease presents a substantial and ongoing global health concern.
- Emerging research highlights inflammation's role in atherosclerosis, alongside vascular injury and homeostasis.
- Potential biomarkers and clinical trial data are being evaluated to test the 'inflammation hypothesis'.
Conclusions:
- A comprehensive understanding of coronary artery disease pathobiology is crucial for advancing diagnosis and management.
- Precision medicine, informed by pathobiology, offers a foundation for personalized strategies in prevention and treatment.
- Further research integrating pathobiology and clinical data is essential for optimizing patient outcomes.
Abstract:
The worldwide prevalence of cardiovascular disease in general and atherosclerotic coronary artery disease in particular is a health and economic concern of unparalleled proportion. Despite a long history of astute observations beginning in 1575 made by Fallopius, followed by those of von Rokatansky, Virchow, Osler, and Ross, and incremental knowledge of the pathobiology of atherosclerosis to include varying stages of inflammation, response to internally and externally mediated vascular injury, and impaired homeostasis, gaps in the field's understanding persist. Here, we summarize the current scope of the problem for coronary artery disease, emerging constructs in its pathobiology and common clinical phenotypes, potentially useful biomarkers, clinical trials designed specifically to test the 'inflammation hypothesis' of disease, and the interface of pathobiology and precision medicine as a foundation for diagnosis, management, and future advances in the diagnosis, prognosis, natural history, prevention, and optimal management.
More Related Videos
09:31Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations